News & Updates

Single-lead ECGs may not be as accurate in detecting AF as previously thought

A new study has challenged previously reported accuracy of atrial fibrillation (AF) detection with single-lead electrocardiograms (ECGs) technology.

Dexmedetomidine protects against new-onset AF in critically ill patients

The use of dexmedetomidine in the intensive care unit (ICU) appears to lower the risk of new-onset atrial fibrillation (AF) in patients, according to a study.

Using visual acuity to guide diabetic macular oedema treatment

Diabetic macular oedema (DME) patients with visual acuity (VA) of 20/50 or worse are likely to experience superior clinically relevant VA outcomes at 1 year and over 2 years using aflibercept vs bevacizumab or ranibizumab, according to an analysis of Diabetic Retinopathy Clinical Research (DRCR) Network’s Protocol T data presented at the 38^th Asia-Pacific Academy of Ophthalmology (APAO 2023) Congress.

Managing MDR gram-negative bacterial infections: Key lessons from 5 years of using ceftazidime-avibactam

The rapid emergence of multidrug-resistant (MDR) pathogens is a major and persistent global healthcare problem. In a Pfizer-sponsored symposium held during the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), experts shared lessons drawn from over half a decade of using ceftazidime-avibactam in the management of MDR gram-negative bacterial infections. Prof David Paterson from the National University of Singapore and Dr Maddalena Giannella from Bologna University, Italy chaired the session. 

Among the highlights were real-world evidence (RWE) with ceftazidime-avibactam and how it has shaped the anti-infective therapeutic landscape, the importance of early, appropriate treatment and its place in antimicrobial stewardship strategies, and the roles of microbiology and diagnostics in optimizing treatment strategies.